EHA Guidelines by Topic
AL Amyloidosis
- Guidelines for high dose chemotherapy and stem cell transplantation for systemic AL amyloidosis: EHA-ISA working group guidelines (2021)
- Guidelines for non-transplant chemotherapy for treatment of systemic AL amyloidosis: EHA-ISA working group (2022)
Anemia
- Recommendations regarding splenectomy in hereditary hemolytic anemias (2017)
- Management of Pregnancy in Rare Inherited Anemias (2020)
- The Use of Next-generation Sequencing in the Diagnosis of Rare Inherited Anaemias: A Joint BSH/EHA Good Practice Paper (2022)
Bleeding and thrombosis
- EHA Guidelines on management of antithrombotic treatments in thrombocytopenic patients with cancer (2022)
Bleeding disorders
- Antithrombotic Treatment in Patients With Hemophilia: an EHA-ISTH-EAHAD-ESO Clinical Practice Guidance (2023)
- Fundamentals for a Systematic Approach to Mild and Moderate Inherited Bleeding Disorders: An EHA Consensus Report (2019)
Cardiovascular toxicity of anti-cancer treatments
CMML
Infections
Lymphomas
- Human immunodeficiency virus-associated Lymphomas: EHA-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
- Primary central nervous system lymphomas: EHA–ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up (2024)
Multiple Myeloma
- Guidelines for the Use and Reporting of Patient-Reported Outcomes in Multiple Myeloma Clinical Trials (2023)
- Multiple Myeloma: EHA-ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up (2021)